Clinical Trials Sponsored by Bastyr University

Total 219696 results

Losordo, Douglas, M.D.
Baxter Healthcare Corporation

Completed

Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia (ACT34-CLI)

Peripheral Vascular Disease | Peripheral Artery Disease | Critical Limb Ischemia

United States
Nguyen, Davis B., M.D.
Baxter BioScience

Unknown

Efficacy and Safety of Fibrin Sealant (FS) VH S/D-APR for Hemostasis and Wound Healing in Endoscopic Browlift

Compare Ecchymosis and Edema for Fibrin Sealant and no Fibrin Sealant

United States
Massachusetts General Hospital
Baxter Healthcare Corporation

Completed

EASI Access II --- Follow-up Study to the EASI Access Trial

Disaster Medicine | Dehydration | Difficult Intravenous Access

United States
Elisabethinen Hospital
Baxter Healthcare Corporation; ASOKLIF

Unknown

Evaluation of Immunogenicity of Different Tick Borne Encephalitis (TBE) Fast Protective Traveler Schemes With Inactivated TBE Whole Virus Vaccine (immunisation)

Tick Borne Encephalitis

Austria, Czech Republic
Massachusetts General Hospital
Baxter Healthcare Corporation

Completed

Recombinant Hyaluronidase in Out-of-Hospital Setting: The EASI Access Trial

Dehydration | Mass Casualty Incident

United States
Geert Wanten
Baxter Healthcare Corporation

Completed

Essential Fatty Acid Status & Immune Function in Parenteral Nutrition Patients

Intestinal Failure

Netherlands
University of Milan
Baxter Healthcare Corporation; Pr Giampiero CAMPANELLI

Completed

Efficacy Study of Tissucol/Tisseel Fibrin Sealant to Treat Inguinal Hernia

Inguinal Hernia

Belgium, Denmark, France, Germany, Spain, United Kingdom
University of Texas Southwestern Medical Center
Baxter Healthcare Corporation

Completed

Airway Responses During Desflurane Anesthesia Via a Laryngeal Mask Airway: Effects of Fentanyl Pretreatment

Administration Site Reaction

United States
Genfit
Naturalpha; SGS Aster S.A.S.

Completed

Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505

Cardiovascular Diseases | Metabolic Diseases | Diabetes Mellitus, Type 2 | Type 2 Diabetes | Dyslipidemia | Obese

France
Baxalta now part of Shire
Baxter Healthcare, Ltd. (New Zealand), Baxter Healthcare Pty. Ltd. (Australia)

Completed

Pharmacokinetic Study of ARALAST (Human Alpha1- PI)

Alpha 1-Antitrypsin Deficiency

Australia, New Zealand
Manchester University NHS Foundation Trust
Baxter Healthcare Corporation; Manchester Metropolitan University

Completed

Comparison of MCO HD on Markers of Vascular Health Compared With On-Line Haemodiafiltration (MoDal)

Cardiovascular Diseases | Inflammation | End Stage Renal Disease

United Kingdom
Centre Hospitalier Universitaire, Amiens
Baxter Healthcare Corporation

Recruiting

Effect of Oxiris® Membrane on Microcirculation Following Cardiac Surgery Under Cardiopulmonary Bypass: a Pilot Prospective Monocentric Study (Oxicard Study). (OXICARD)

Surgery | Cardiac Event

France
Ottawa Hospital Research Institute
Baxter Healthcare Corporation

Completed

Buttonhole Versus Step Ladder Cannulation in High Dose Hemodialysis

Renal Failure

Canada
Johannes Jakobsen
Baxter Healthcare Corporation

Completed

Efficacy and Safety of HyQvia (Immunoglobulin 10% With Recombinant Hyaluronidase) in Multifocal Motor Neuropathy (MMN)

Multifocal Motor Neuropathy

Denmark
IRCCS Policlinico S. Matteo
Baxter Healthcare Corporation

Completed

Integrative Parenteral Nutrition in Cancer Patients

Neoplasms | Parenteral Nutrition

Italy
Lawson Health Research Institute
Baxter Healthcare Corporation

Completed

Use of a Bimodal Solution for Peritoneal Dialysis

End Stage Renal Disease

Canada
Baxter Healthcare Corporation
Gambro Renal Products, Inc.

Completed

Molecule Removal and Ease of Use: A Comparison of Two Different Dialyzers

Chronic Kidney Disease

United States
Baxter Healthcare Corporation
Gambro Renal Products, Inc.

Completed

Ease of Use Study for the Gambro Polyflux HD-C4 Small Dialyzer

Hemodialysis

United States
Scripps Translational Science Institute
Baxter Healthcare Corporation

Withdrawn

Pilot Study of the CoVa™ Monitoring of Patients With Congestive Heart Failure (CoVa)

Congestive Heart Failure

United States
Central Hospital, Nancy, France
Baxter Healthcare Corporation

Unknown

Esmolol Effects on Heart and Inflammation in Septic Shock (ESMOSEPSIS)

Septic Shock

France
Karolinska Institutet
Baxter Healthcare Corporation; Region Stockholm

Completed

Long-term Survival and Renal Outcomes in Critically Ill Patients After Acute Kidney Injury: Swedish Multi-centre Cohort Study

Acute Kidney Injury
Lawson Health Research Institute
Baxter Healthcare Corporation

Completed

Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL

End Stage Renal Disease

Canada
Hospices Civils de Lyon
Baxter Healthcare Corporation

Completed

Endotoxins and Cytokines Removal During Continuous Hemofiltration With oXiris™ (ECRO)

Septic Shock | Peritonitis

France
Baxter Healthcare Corporation
University of Louisville; Gambro Renal Products, Inc.

Completed

A Pilot Study of a Heparin Dosing Algorithm for Hemodialysis

Renal Failure Chronic Requiring Hemodialysis

United States
University Hospital, Saarland
Baxter Healthcare Corporation; Pharmacia GmbH, Erlangen, Germany

Completed

Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) (TAHHT)

Hereditary Hemorrhagic Telangiectasia

Germany
aTyr Pharma, Inc.

Completed

Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD) (FSHD)

Facioscapulohumeral Muscular Dystrophy | Limb Girdle Muscular Dystrophy

United States, Denmark, Italy
aTyr Pharma, Inc.

Completed

Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Participants With Muscular Dystrophy

Facioscapulohumeral Muscular Dystrophy (FSHD)

United States, Netherlands, France, Italy
Duke University
United States Department of Defense; Baxter Healthcare Corporation

Not yet recruiting

Personalized Nutrition to Improve Recovery in Trauma (SeND Home)

Abdominal Trauma

United States
First Affiliated Hospital, Sun Yat-Sen University
Baxter Healthcare Corporation

Recruiting

Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis

Peritoneal Dialysis

China
Federal University of Minas Gerais
Baxter Healthcare Corporation; Medtronic - MITG

Completed

Recovery Profile Comparison Between Remifentanil-propofol or Desflurane Anesthesia Monitored With Bispectral Index.

Delayed Emergence From Anesthesia
University of Alberta
Baxter Healthcare Corporation; Fresenius Kabi; Nutricia Advanced

Completed

International Nutrition Audit in FORegut TuMors (INFORM)

Head and Neck Cancer | Esophageal Cancer

Australia, United States, Canada, Italy, Netherlands
FRANCO TURANI
Baxter Healthcare Corporation

Unknown

The Membrane Adsorbing OXiris Filter in Septic Patients With AKI (MOSAKI)

Sepsis | Acute Renal Failure

Italy
Kook-Hwan Oh
Baxter Healthcare Corporation

Completed

Trial on Education And Clinical Outcomes for Home PD Patients (TEACH) (TEACH)

Risk Reduction

Korea, Republic of
Second Xiangya Hospital of Central South University
Baxter Healthcare Corporation

Unknown

Residual Renal Function Preservation in Peritoneal Dialysis Patients

Chronic Renal Disease

China
Shanghai Jiao Tong University School of Medicine
Baxter Healthcare Corporation

Unknown

The Effect of Systemic Dietary Instruction on Management of Plasma Phosphorus Levels in Peritoneal Dialysis (PD) Patients

Hyperphosphatemia

China
Lawson Health Research Institute
Baxter Healthcare Corporation

Not yet recruiting

An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL

End Stage Renal Disease
Hospital Universitari de Bellvitge
Baxter Healthcare Corporation

Completed

Antibiotic Plasma Concentrations During Continuous Renal Replacement Therapy With a High Adsorption Membrane (oXiris®)

Sepsis | Acute Kidney Injury | Hemodiafiltration

Spain
Sadaf Bashir

Enrolling by invitation

Pain Reduction After Separators Placement

Orthodontic Pain

Pakistan
Baxter Healthcare Corporation
Gambro Renal Products, Inc.

Completed

Gambro AK200 ULTRA Hemodiafiltration Study

Chronic Renal Failure

United States
Baxter Healthcare Corporation
Gambro Renal Products, Inc.

Completed

Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)

Liver Failure | Liver Cirrhosis | Hepatic Encephalopathy | Hepatitis, Chronic

United States, Belgium, Denmark
Medical College of Wisconsin
Baxter Healthcare Corporation

Withdrawn

Novel Testing Procedures

Immunodeficiencies

United States
Minneapolis Heart Institute Foundation
Baxter Healthcare Corporation

Completed

Quality of Life in Patients With Refractory Angina

Refractory Ischemia

United States
Hospital Authority, Hong Kong
Baxter Healthcare Corporation

Completed

Study on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

Prostatic Neoplasms | Bone Density

China
Rigshospitalet, Denmark
Baxter Healthcare Corporation; Aesculap AG

Completed

Predisposing Factors for Chronic Postherniotomy Pain

Chronic Postherniotomy Pain

Denmark, Germany
aTyr Pharma, Inc.

Completed

Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD) (FSHD)

Limb-Girdle Muscular Dystrophies | Facioscapulohumeral Muscular Dystrophy

United States, Denmark, France
aTyr Pharma, Inc.

Completed

Evaluate Safety and Biological Activity of ATYR1940 in Participants With Early Onset Facioscapulohumeral Muscular Dystrophy (FSHD)

Facioscapulohumeral Muscular Dystrophy (FSHD)

United States, France, Italy
aTyr Pharma, Inc.

Completed

Safety, Tolerability, Pharmacokinetics (PK), and Activity of ATYR1940 in Participants With Muscular Dystrophy - Study Extension

Facioscapulohumeral Muscular Dystrophy

United States, Italy, Netherlands
Baxter Healthcare Corporation
University of Louisville; Gambro Renal Products, Inc.

Completed

Comparative Effects Of Dialysate Flow Rate And Membrane Packing On The Performance Of Dialyzers Used For Hemodialysis

Chronic Kidney Disease | Chronic Renal Disease

United States
aTyr Pharma, Inc.

Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

Interstitial Lung Disease

United States
aTyr Pharma, Inc.

Completed

Study to Evaluate the Safety and Efficacy of ATYR1923 (Efzofitimod) In Participants With Severe Pneumonia Related to COVID-19

SARS-CoV-2 (COVID-19) Severe Pneumonia

United States, Puerto Rico

Clinical Trials Sponsored by Bastyr University

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations